Dear Member

For the PQS support from PharmaPlus we have planned on releasing weekly emails of bite size chunks as per previous years explaining what needs doing and how to claim. Please see topics below. You can click on the topics below to review previous emails.

TOPIC 1 sent on 7 Nov'23: High Risk Medicines - Anticoagulation Audit

TOPIC 2 sent on 24 Nov'23: Asthma and Respiratory Domain for PQS

TOPIC 3 sent on 11 Dec'23: Antimicrobial Stewardship for PQS

TOPIC 4 sent on 15 Dec'23: Antimicrobial Stewardship for PQS Email 2

TOPIC 5 sent on 18 Dec'23: Antimicrobial Stewardship for PQS Email 3

TOPIC 5 THIS EMAIL: Medicines Safety and Optimisation- Palliative care

Medicines Safety and Optimisation- Palliative care

This is the final part of the medicines safety and optimisation domain of PQS which needs to be completed, if you haven’t done it already.

WHAT TO DO

Part 1- NHS Profile manager Update

For those members who hold the below stock routinely, please update your NHS profile manager to show that you are a ‘Pharmacy palliative care medication stockholder’.

The deadline is 31^st March 2024, however, we strongly suggest that you complete this as soon as possible if you haven’t already.

If you do not stock the above items routinely then you do not have to do anything to your NHS profile manager in relation to this.

The 16 critical medicines for palliative and end of life care are: 

• Cyclizine solution for injection ampoules 50mg/1ml 

• Cyclizine tablets 50mg 

• Dexamethasone solution for injection ampoules 3.3mg/1ml

• Dexamethasone tablets 2mg 

• Haloperidol tablets 500mcg  

• Hyoscine butylbromide solution for injection 20mg/1ml 

• Levomepromazine solution for injection ampoules 25mg/1ml 

• Metoclopramide solution for injection ampoules 10mg/2ml

• Midazolam solution for injection ampoules 10mg/2ml 

• Morphine sulfate oral solution 10mg/5ml   

• Morphine sulfate solution for injection ampoules 10mg/1ml 

• Morphine sulfate solution for injection ampoules 30mg/1ml

• Oxycodone solution for injection ampoules 10mg/1ml 

• Oxycodone oral solution sugar free 5mg/5ml 

• Sodium chloride 0.9% solution for injection ampoules 10ml 

• Water for injections 10ml

Part 2- Action Plan

An action plan must be in place to state what is to be one if you do not have the above stock or parenteral haloperidol (even if you do not routinely stock these). 

You may update the one from PQS 2022/2023

Please include:

- Local pharmacies who hold the above stock routinely

- Details of locally commissioned services where the above stock can be obtained

- Details of locally commissioned palliative care services, including on-call arrangements.

- Awareness of support services which would be helpful to parent/carers.

HOW TO REPORT

On MYS confirm either:

• You do not hold the stock routinely.
• You have updated your NHS Profile manager if you do routinely hold stock.

AND

• Declare that you have an Action plan in place and is available to be reviewed should the need arise.

If you have any questions or inquiries please get in touch with us as usual on

 info@pharmaplusltd.co.uk

Regards,

PharmaPlus